Minerva Neurosciences Inc (NERV)
NERV trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.52
-12.98% on the day
Market cap
$120.1M
Micro cap
Revenue · 2024
$0
Prior year not contiguous
Net income · 2024
$1.4M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | NERV on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001598646 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | MA |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | $1.4M |
| Operating income | -$21.8M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $21.4M |
| Total assets | $37.1M |
| P/E (computed) | 83.5× |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-27 |
| Latest annual report | 10-K | 2026-03-11 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-08-12 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 643 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals Inc. | $2.70 | -5.26% | $116.9M |
| SPRB | Spruce Biosciences Inc. | $40.35 | -5.88% | $116.0M |
| PDSB | PDS Biotechnology Corporation | $1.60 | +5.26% | $116.0M |
| KZIA | Kazia Therapeutics Limited | $8.04 | -8.74% | $125.0M |
| HURA | TuHURA Biosciences Inc. | $1.81 | -4.74% | $115.3M |
| GNLX | Genelux Corporation | $2.52 | -0.98% | $114.0M |
| VTVT | vTv Therapeutics Inc. | $28.23 | -7.32% | $111.6M |
| OGI | Organigram Global Inc. Common Shares | $0.9190 | -1.68% | $129.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier